Clinical Trial Update: Percutaneous Hemodynamic Support With Impella 2.5 During Scar-related Ventricular Tachycardia Ablation [NA]

View source ↗

Summary

A completed clinical trial evaluating percutaneous hemodynamic support with the Impella 2.5 during scar-related ventricular tachycardia ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Drugs mentioned

• Impella 2.5 (Impella 2.5)

Snippet

Sponsor: Vivek Reddy | Conditions: Ventricular Tachycardia | NA | Status: COMPLETED | Results posted: 2018-02-14